4.7 Article

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa

期刊

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 53, 期 11, 页码 4783-4788

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00574-09

关键词

-

资金

  1. Ministere de l'Education Nationale et de la Recherche [UPRES-EA3539]
  2. Universite Paris XI, Paris, France
  3. European community [DRESP2, LSHM-CT-2005-018705]
  4. TROCAR [HEALTH-F3-2008-223031]
  5. INSERM
  6. Ministerio de Educacion y Ciencia from Spain [2007/0292]

向作者/读者索取更多资源

The contributions of different mechanisms of resistance to carbapenems among a collection of imipenemand meropenem-nonsusceptible Pseudomonas aeruginosa isolates were investigated. This screening included the recently reported extended-spectrum cephalosporinases (ESACs) weakly hydrolyzing carbapenems. Eighty-seven percent of the studied isolates were resistant to imipenem. Genes encoding metallo-beta-lactamases or carbapenem-hydrolyzing oxacillinases were not identified. The main mechanism associated with imipenem resistance was the loss of outer membrane protein OprD. Identification of overexpressed ESACs and loss of OprD were observed for 65% of the isolates, all being fully resistant to imipenem. Resistance to meropenem was observed in 78% of the isolates, with all but one also being resistant to imipenem. Overexpression of the MexAB-OprM, MexXY-OprM, or MexCD-OprJ efflux systems was observed in 60% of the isolates, suggesting the contribution of efflux mechanisms in resistance to meropenem. The loss of porin OprD and the overproduction of ESACs were observed in 100% and 92% of the meropenem-resistant isolates, respectively. P. aeruginosa can very often accumulate different resistance mechanisms, including ESAC production, leading to carbapenem resistance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据